5 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Unknown 3 |
Follow Zhebao Wu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Endoscopic Pituitary Surgery on Nasal Function Single nostril approach endoscopic transsphenoidal pituitary surgery, Bilateral nostril approach endoscopic transsphenoidal pituitary surgery - Pituitary Tumor, Endoscopic Surgery | Unknown | Zhebao Wu | 100 | 2019-07-25 | 2020-10-09 | |
| Dopamine D2 Receptors(D2R) Imaging in Prolactinomas Surgery, Drug treatment - Prolactinoma | Not applicable | Unknown | Zhebao Wu | 50 | 2018-12-01 | 2018-11-20 |
| Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA) Drug treatment, Surgery - Pituitary Adenoma | Not applicable | Unknown | Zhebao Wu | 50 | 2018-11-01 | 2018-10-22 |
| Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas HCQ/CQ and CAB combined treatment - Resistance, Disease, Prolactinoma | Not applicable | Unknown | Zhebao Wu | 30 | 2018-10-25 | 2018-10-16 |
| Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus Invasive Prolactinomas Involving the Cavernous Sinus | Unknown | Zhebao Wu | 30 | 2016-06-01 | 2017-05-16 |
Prolactinoma (3) · Pituitary Neoplasms (2) · Disease Resistance (1)
Surgical Procedures, Operative (2)
China (3)
PMID 27864853, PMID 18780796, PMID 21296991, PMID 21748460, PMID 22863387, PMID 25024426, PMID 28973192